Journal article
E6AP promotes prostate cancer by reducing p27 expression
D Raghu, PJ Paul, T Gulati, S Deb, C Khoo, A Russo, E Gallo, G Blandino, AL Chan, E Takano, SK Sandhu, SB Fox, S Williams, S Haupt, C Gamell, Y Haupt
Oncotarget | IMPACT JOURNALS LLC | Published : 2017
Abstract
Prostate cancer (PC) is the most common cancer in men. Elevated levels of E3 ligase, E6-Associated Protein (E6AP) were previously linked to PC, consistent with increased protein expression in a subset of PC patients. In cancers, irregular E3 ligase activity drives proteasomal degradation of tumor suppressor proteins. Accordingly, E3 ligase inhibitors define a rational therapy to restore tumor suppression. The relevant tumor suppressors targeted by E6AP in PC are yet to be fully identified. In this study we show that p27, a key cell cycle regulator, is a target of E6AP in PC. Down regulation of E6AP increases p27 expression and enhances its nuclear accumulation in PC. We demonstrate that E6AP..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by CCV grant (1085154), and NHMRC project grant (1063389), PCF creativity grant to SW and YH, and VCA Richard Pratt Fellowship in Prostate Cancer Research to CG.